Skip to content

Effect of perioperative remote ischemic conditioning on perioperative myocardial injury in patients with unstable angina treated with percutaneous coronary intervention: a prospective, multicenter, randomized controlled clinical trial

Effect of perioperative remote ischemic conditioning on perioperative myocardial injury in patients with unstable angina treated with percutaneous coronary intervention: a prospective, multicenter, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079855
Enrollment
Unknown
Registered
2024-01-15
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable angina

Interventions

Experimental group:Remote ischemic conditioning (RIC)
Control group:Sham Remote ischemic conditioning (Sham RIC)

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unstable angina (primary angina, worsening angina, resting angina, post-infarction angina, variant angina) who are scheduled for coronary angiography 2. Be older than 18 years and younger than or equal to 75 years of age 3. Have normal cognitive function, MMSE score >16, and be able to cooperate with rehabilitation therapy 4. Agree to participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. hs-cTnT elevation greater than 2 times the upper limit of normal (99th percentile of the upper reference limit) in combination with other evidence of myocardial ischemia 2. Stroke or myocardial infarction within 30 days 3. Thrombolytic therapy within 30 days 4. Uncontrolled hypertension: systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg 5. Contraindication to physiologic ischemia training, vascular or soft tissue injury, etc. 6. The presence of peripheral neuropathy, peripheral arterial disease, superficial thrombophlebitis, acute venous thrombosis 7. Other reasons that the investigator considers inappropriate for enrollment.

Design outcomes

Primary

MeasureTime frame
Periprocedural myocardial injury;

Secondary

MeasureTime frame
Periprocedural myocardial infarction;Major adverse cardiac events (MACE);All-cause mortality;Myocardial infarction;Rehospitalization for heart failure;Unplanned revascularization;Gensini Score;Arrhythmia;Seattle Angina Questionnaire (SAQ);Two-dimensional echocardiography;

Countries

P.R. China

Contacts

Public ContactXiao Lu

The First Affiliated Hospital of Nanjing Medical University

luxiao1972@163.com+86 138 1395 8023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026